longevity study diversity
Longevity Science Reviewed - Diverse Representation?
Only 12% of participants in major longevity trials are non-white, meaning the findings largely reflect white physiology. This low diversity limits how well results apply to the broader public, from dosage recommendations to efficacy predictions. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.